Page last updated: 2024-10-29

ketoconazole and Encephalitis, Venezuelan Equine

ketoconazole has been researched along with Encephalitis, Venezuelan Equine in 1 studies

1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schroeder, CE1
Yao, T1
Sotsky, J1
Smith, RA1
Roy, S1
Chu, YK1
Guo, H1
Tower, NA1
Noah, JW1
McKellip, S1
Sosa, M1
Rasmussen, L1
Smith, LH1
White, EL1
Aubé, J1
Jonsson, CB1
Chung, D1
Golden, JE1

Other Studies

1 other study available for ketoconazole and Encephalitis, Venezuelan Equine

ArticleYear
Development of (E)-2-((1,4-dimethylpiperazin-2-ylidene)amino)-5-nitro-N-phenylbenzamide, ML336: Novel 2-amidinophenylbenzamides as potent inhibitors of venezuelan equine encephalitis virus.
    Journal of medicinal chemistry, 2014, Oct-23, Volume: 57, Issue:20

    Topics: Animals; Antiviral Agents; Benzamides; Drug Evaluation, Preclinical; Encephalitis Virus, Venezuelan

2014